Contrary to prior data, this study shows that neither eosinophils nor STAT6-mediated IL-4/IL-13 signaling contribute ...

While the last decade has brought considerable progress for patients with DMD, substantial unmet need remains. Several ...

Duchenne muscular dystrophy occurs when that gene fails ... These may include: Muscle biopsy. A small piece of muscle tissue is removed and examined to confirm the diagnosis or rule out another ...

What Is Duchenne Muscular Dystrophy? Muscular dystrophies are a ... your child might have other symptoms, including: The muscle problems can cause cramps at times, but in general, DMD isn ...

BOSTON - Entrada Therapeutics , Inc. (NASDAQ:TRDA) received authorization from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) to initiate a Phase 1/2 clinical trial for its ...

The data showed reduced difficulties in standing, walking and running that were statistically significant, the company said.

Tazeen Ahmad, an analyst from Bank of America Securities, maintained the Buy rating on Sarepta Therapeutics (SRPT – Research Report). The ...

Muscular Dystrophy (MD) is a genetic condition causing progressive muscle weakness and complications in vital organs. Early diagnosis, multidisciplinary care, and emerging treatments like gene therapy ...

Also Read: Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy Dyne ... Analysis of muscle biopsy data for the 6.8 mg/kg Q8W cohort ...

Analyst Gil Blum from Needham maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) and keeping the price target at ...

Santhera Pharmaceuticals will launch its new drug for Duchenne muscular dystrophy in the UK within ... that has been shown in trials to slow down muscle degeneration and prolong the ability ...